Tianjin Medical University Eye Hospital
Tianjin, Tianjin Municipality, 120120, China
NCT Number: NCT07186088
To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light
Trial opening soon.
Get Notified18 year–35 year
All sexes
Interventional
Not applicable
Tianjin, Tianjin Municipality, 120120, China
The experiment will be divided into two phases. In the first phase, the subjects will be randomly grouped using laser equipment and LED equipment, and each group will be exposed to the red light twice a day for one month. The second stage involves self-comparison of the laser equipment, with the usage frequencies being once a day and three times a day.
To explore the effectiveness and safety of repeated exposure to repeated low-intensity red light in different devices and frequencies, as well as its impact on the axial length, spherical equivalent refraction and choroidal thickness of myopia progression.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Eyerising RS-200-2A,1 time,2 times, 3 times a day
Eyerising RS-200-2A,2 times a day
Time frame: From enrollment to the end of treatment up to 7 months
Time frame: From enrollment to the end of treatment up to 7 months
Time frame: From enrollment to the end of treatment up to 7 months
Trial opening soon.
Get NotifiedRuihua Wei
Other
Study on the Therapeutic Efficacy of Different Repeated Low-Intensity Red Light Devices and Different Usage Frequencies for Adult Myopia Treatment
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07839091
Eye Diseases, Myopia
Singapore
View Trial DetailsNCT07829419
Astigmatism, Eye Diseases
New York, United States
View Trial DetailsNCT07825428
Eye Diseases, Myopia
Guiyang, Guizhou, China
View Trial DetailsNCT07810725
Astigmatism, Eye Diseases
View Trial Details